Answers are grounded in this paper and cite their sources.
Nasopharyngeal cancer (NPC) is a malignant tumor of the head and neck, which is extremely sensitive to radiotherapy. The aim of this study is to evaluate the feasibility of a label-free nanobiosensor based on plasma surface-enhanced Raman spectroscopy (SERS) to assess the radiotherapy effect in NPC. Here, SERS measurements were performed on plasma samples from 40 pre-treatment and post-treatment NPC as well as 30 healthy volunteers. Results demonstrate that the spectral characteristic of post-treatment samples is obviously different from that of pre-treatment ones, owing to the changes of biomolecules in plasma induced by radiotherapy. Classification sensitivities of 83.3%, 61.8% and 95.1%, and specificities of 91.2%, 67.4% and 93% can be achieved for separating pre- and post-treatment samples, post-treatment and normal samples, and pre-treatment and normal samples, respectively, suggesting the great potential of plasma SERS method as a rapid and convenient tool for radiotherapy assessment and cancer screening in NPC.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: